US/Ireland: For the fourth quarter of 2025, ending 31 December 2025, CRH reported total revenues of US$9.4bn, up by 6% year-on-year. Net income was US$1.0bn during the period, which represents a significant 46% year-on-year increase from the previous corresponding quarter. Adjusted earnings before interest, taxation, depreciation and amortisation (EBITDA) were US$2.0bn, up by 14% year-on-year.
In the full 2025 financial year, CRH reported total revenues of US$37.4bn, up by 5% from US$35.6bn in 2024, reportedly driven by favourable demand and acquisitions. Net income was US$3.8bn, up by 8% from US$3.5bn in 2024. Adjusted EBITDA was US$7.7bn, up by 11% from US$6.9bn in 2024.
CEO Jim Mintern said “2025 proved to be a year of significant progress for CRH, with double-digit adjusted EBITDA growth, delivering another record performance and reinforcing our position as the leading compounder of capital in our industry. We enter 2026 with confidence and expect favourable end-market dynamics as well as the continued execution of our superior strategy to underpin another year of growth and value creation for our shareholders.”
CRH reports financial results for fourth quarter of 2025 and full financial year
